Funder: The Mark Foundation for Cancer Research
Due Dates (Anticipated): September 2025 (LOI portal opens) | November 2025 (LOI deadline) | March 2026 (Full application invitations) | September 2026 (Award start)
Funding Amounts: Up to $1,000,000 total for 12–36 months (including direct and indirect costs; indirects capped at 10% of directs)
Summary: Supports academic researchers in advancing novel cancer therapies from discovery through early lead development, with funding and biopharma expert guidance.
Key Information: LOIs accepted from non-profit research institutions worldwide; full applications by invitation only.